Losing 25 kg of Pure Fat with Mounjaro: Patient Story

August 1, 20260:52Patient stories

In this video, a patient shares her experience using Mounjaro as a non-surgical alternative to gastric sleeve surgery, successfully dropping from 123 kg to 98 kg over 5 months. The most important achievement was losing 25 kg of pure body fat while preserving lean muscle mass through regular InBody body composition assessments. The patient explains how the clinical program helped control emotional eating episodes and intense sugar cravings without severe side effects, noting only mild fatigue on the first day following each dose. The experience highlights how gradual medical dose escalation protects metabolism and ensures lasting results.

Key points

Lost 25 kg of pure body fat in 5 months, moving from 123 kg to 98 kg.
Preservation of lean muscle mass tracked by InBody scans.
Control over emotional eating and intense sugar cravings.
Mild side effects limited only to the first day after injection.

Read the full article

About this video in detail

This video looks at mounjaro weight loss results through one patient’s experience, moving from 123 kg to 98 kg over 5 months. The important question is not only how much weight changed, but where that change came from. Her story presents Mounjaro as a non surgical sleeve alternative for some patients after medical assessment, with body composition followed alongside the scale.

The focus is fat loss without muscle loss. An InBody composition test was used during follow-up to distinguish changes in fat from changes in lean tissue. In this patient’s case, the 25 kg reduction was described as mostly fat, while emotional eating and stopping sugar cravings also became easier to manage.

She describes mild fatigue on the first day after an injection, with no severe problem reported in the video. This is useful for anyone comparing personal experience with general expectations. Read more about what to expect from Mounjaro results and protecting muscle during weight loss, then learn how waist and InBody measures relate in visceral fat follow-up. The wider lesson is to track appetite, daily energy and eating patterns alongside body composition rather than treating a testimonial as a forecast. The first-day timing also shows why symptoms belong in follow-up rather than in a generic expectation.

Frequently asked questions

Mounjaro weight loss results vary with the person, treatment plan, health history and response. In this video, the patient lost 25 kg over 5 months, with the reduction described as mostly fat in her case. That is an individual story, not a promised result, and the clinician decides how progress should be assessed.

Muscle preservation depends on adequate nutrition, activity and follow-up, not the injection alone. In this patient’s case, InBody monitoring showed preserved muscle alongside fat loss. The guide to protecting muscle during weight loss explains why composition matters more than the scale alone.

Mounjaro may be a non surgical option for some people with excess weight, but it is not suitable for everyone and does not replace medical assessment. The video shows one patient’s experience. Health history, medicines, goals and examination findings all affect the decision.

An InBody composition test can help track whether a change in weight is coming mainly from fat, lean tissue or fluid estimates. In this case, it was used to follow the quality of the loss. The trend and clinical context matter more than treating one reading as a diagnosis. The waist and visceral-fat discussion in the related measurement guide adds useful context.